RNA-seq of human breast cancer cell line MDA-MB-231 treated with STM2457 against untreated controls
Here, we aim to investigate if catalytic inhibition of the m6A methyltransferase METTL3 by the small-molecule STM2457  may be a viable treatment option for TNBC.